- Home
- SNN vs IVZ Comparison
SNN vs IVZ Comparison
Compare SNN & IVZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SNN | IVZ |
|---|---|---|
| Founded | 1856 | 1935 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 13.9B |
| IPO Year | 2002 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SNN | IVZ |
|---|---|---|
| Price | $28.98 | $32.85 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 15 |
| Target Price | ★ $36.25 | $27.43 |
| AVG Volume (30 Days) | 1.3M | ★ 4.0M |
| Earning Date | 03-16-2026 | 04-28-2026 |
| Dividend Yield | 2.48% | ★ 3.35% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.27 |
| Revenue | N/A | ★ $5,314,100,000.00 |
| Revenue This Year | $8.58 | N/A |
| Revenue Next Year | $5.60 | $5.83 |
| P/E Ratio | $64.97 | ★ $26.23 |
| Revenue Growth | N/A | ★ 2.98 |
| 52 Week Low | $28.56 | $20.67 |
| 52 Week High | $38.79 | $33.65 |
Technical Indicators
Market Signals| Indicator | SNN | IVZ |
|---|---|---|
| Relative Strength Index (RSI) | 39.74 | 67.14 |
| Support Level | $28.87 | $31.15 |
| Resistance Level | $30.52 | N/A |
| Average True Range (ATR) | 0.38 | 0.74 |
| MACD | -0.09 | 0.03 |
| Stochastic Oscillator | 9.47 | 89.26 |
Price Performance
Historical ComparisonAbout SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.
About IVZ Invesco Ltd
Invesco provides investment management services to retail (69% of managed assets) and institutional (31%) clients. At the end of May 2026, the firm had $2.454 trillion in assets under management spread among its equity (61% of AUM), balanced (3%), fixed-income (21%), alternative investment (6%), and money market (9%) operations. Passive products account for close to half of Invesco's total AUM. Invesco's US retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside of North America, with 32% of its AUM sourced from Europe, Africa, and the Middle East (17%) and Asia (15%).